Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 12(1): 21477, 2022 12 12.
Article in English | MEDLINE | ID: mdl-36509821

ABSTRACT

The Antarctic continent is one of the most inhospitable places on earth, where living creatures, mostly represented by microorganisms, have specific physiological characteristics that allow them to adapt to the extreme environmental conditions. These physiological adaptations can result in the production of unique secondary metabolites with potential biotechnological applications. The current study presents a genetic and antibacterial characterization of four Antarctic fungi isolated from soil samples collected in Pedro Vicente Maldonado Scientific Station, at Fort William Point, Greenwich Island, Antarctica. Based on the sequences of the internal transcribed spacer (ITS) region, the fungi were identified as Antarctomyces sp., Thelebolus sp., Penicillium sp., and Cryptococcus gilvescens. The antibacterial activity was assessed against four clinical bacterial strains: Escherichia coli, Klebsiella pneumoniae, Enterococcus faecalis, and Staphylococcus aureus, by a modified bacterial growth inhibition assay on agar plates. Results showed that C. gilvescens and Penicillium sp. have potential antibiotic activity against all bacterial strains. Interestingly, Thelebolus sp. showed potential antibiotic activity only against E. coli. In contrast, Antarctomyces sp. did not show antibiotic activity against any of the bacteria tested under our experimental conditions. This study highlights the importance of conservation of Antarctica as a source of metabolites with important biomedical applications.


Subject(s)
Ascomycota , Penicillium , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/metabolism , Escherichia coli/genetics , Escherichia coli/metabolism , Fungi/genetics , Ascomycota/genetics , Bacteria/metabolism , Penicillium/genetics , Penicillium/metabolism , Antarctic Regions
2.
Vet Clin North Am Food Anim Pract ; 37(2): 253-266, 2021 Jul.
Article in English | MEDLINE | ID: mdl-34049657

ABSTRACT

Studies have sought to develop effective vaccines against infectious bovine keratoconjunctivitis (IBK). Most research has focused on parenterally administered vaccines against Moraxella bovis antigens; however, researchers have also included Moraxella bovoculi antigens in vaccines to prevent IBK. Critical knowledge gaps remain as to which Moraxella spp antigens might be completely protective, and whether systemic, mucosal, or both types of immune responses are required for protection against IBK associated with Moraxella spp. Immune responses to commensal Moraxella spp residing in the upper respiratory tract and eye have not been analyzed to determine if these responses control colonization or contribute to IBK.


Subject(s)
Bacterial Vaccines/immunology , Cattle Diseases/prevention & control , Keratoconjunctivitis, Infectious/prevention & control , Moraxella bovis/immunology , Moraxella/immunology , Moraxellaceae Infections/veterinary , Animals , Cattle , Keratoconjunctivitis, Infectious/microbiology , Moraxellaceae Infections/prevention & control
3.
Vet Clin North Am Food Anim Pract ; 37(2): 371-379, 2021 Jul.
Article in English | MEDLINE | ID: mdl-34049666

ABSTRACT

In this article, the authors summarize the future needs from a research perspective to make the greatest gains. They discuss the areas of research: diagnosis, epidemiology, economic impact, prevention, and treatment. In some areas, simple studies with little cost could be conducted that would quickly add to the evidence base. In other areas, substantial investment is needed if new study approaches, which do not repeat past studies' failures, are to be conducted. To maximize the value of research funding, it is essential to critically evaluate the information gains from prior studies and ensure that studies increase knowledge incrementally.


Subject(s)
Bacterial Vaccines/immunology , Cattle Diseases/drug therapy , Keratoconjunctivitis, Infectious/drug therapy , Animals , Cattle , Cattle Diseases/prevention & control , Keratoconjunctivitis, Infectious/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...